Potential prognostic biomarker SERPINA12: implications for hepatocellular carcinoma
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.SERPINA12 is elevated in hepatocellular carcinoma (HCC) tissues, indicating a poor prognosis and diagnostic potential. This biomarker is linked to immune cell infiltration in HCC patients.
Area Of Science
- Oncology
- Molecular Biology
- Cancer Research
Background
- Hepatocellular carcinoma (HCC) is a prevalent malignancy with high mortality.
- Understanding HCC's development mechanisms is crucial.
- The role of SERPINA12 in HCC requires further investigation.
Purpose Of The Study
- To investigate SERPINA12's role in HCC diagnosis.
- To evaluate SERPINA12 for HCC prognosis prediction.
- To explore SERPINA12's biological function in HCC.
Main Methods
- Analyzed TCGA data for SERPINA12 expression and clinical features.
- Used Kaplan-Meier curves for survival analysis.
- Performed enrichment analysis and investigated immune cell infiltration.
- Validated SERPINA12 expression via RT-qPCR and immunohistochemistry in HCC patients.
Main Results
- SERPINA12 expression is significantly higher in HCC tissues compared to normal tissues.
- Elevated SERPINA12 correlates with poor prognosis and is an independent predictor of survival.
- SERPINA12 demonstrates diagnostic potential for HCC.
- SERPINA12 expression is associated with immune cell infiltration in HCC.
Conclusions
- SERPINA12 serves as a promising biomarker for HCC diagnosis and prognosis.
- SERPINA12 expression is linked to immune cell infiltration in HCC.
These videos have been matched automatically. Contact us if they are not relevant.
These videos have been matched automatically. Contact us if they are not relevant.